Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy

van Tienen, F; Zelissen, R; Timmer, E; van Gisbergen, M; Lindsey, P; Quattrocelli, M; Sampaolesi, M; Mulder-den Hartog, E; de Coo, I; Smeets, H

Smeets, H (reprint author), Maastricht Univ, Sch Dev Biol & Oncol GROW, Med Ctr, POB 616, NL-6200 MD Maastricht, Netherlands.; Smeets, H (reprint author), Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Med Ctr, Maastricht, Netherlands.

STEM CELL RESEARCH & THERAPY, 2019; 10 (1):

Abstract

Background Myopathy and exercise intolerance are prominent clinical features in carriers of a point-mutation or large-scale deletion in the mitochondr......

Full Text Link